"Predicting discontinuation of docetaxel treatment for metastatic ..."

Daniel Kristiyanto et al. (2016)

> Home

Details and statistics

DOI: 10.12688/F1000RESEARCH.8353.1

access: open

type: Informal or Other Publication

metadata version: 2023-07-21

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/f1000research/KristiyantoAHY16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/f1000research/KristiyantoAHY16
Daniel Kristiyanto, Kevin E. Anderson, Ling-Hong Hung, Ka Yee Yeung:
Predicting discontinuation of docetaxel treatment for metastatic castration-resistant prostate cancer (mCRPC) with random forest. F1000Research 5: 2673 (2016)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.